Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
CombinatoRx, Incorporated
CombinatoRx Reports Financial Results for the First Quarter 2009
May 30th, 2009
CombinatoRx, Incorporated (NASDAQ: CRXX) reported financial results for the first quarter ended March 31, 2009. “Significant recent accomplishments, including the signing of an oncology-focused collaboration with Novartis and the clinical advancement of a CombinatoRx-derived combination product candidate by our ophthalmic collaborator, Fovea, are evidence that the strategy to focus on our core strengths of identifying novel product candidates based on synergy and selectivity is generating interest and creating value from a partnership perspective,” commented Alexis Borisy, President and CEO of CombinatoRx. Recent Accomplishments and Business Updates: Entered into a...
Source: Law & Health Weekly (2009-05-30)
|
